ARCHIVES

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

December 16, 2005

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

In Brief: Breast Cancer Coalition Delivers 175,000 Letters To Congress; IL Cancer Council Has New Name

October 11, 1991

House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program

October 8, 1999

Capitol Hill: With money tight, support for 2015 goal is symbolic.

October 14, 2005

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011